SCHEMBL23645441

SCHEMBL23645441

N#Cc1ccc2c(c1)CC(NC(=O)c1cc3n(n1)CCC(c1ccccc1F)O3)CO2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MALT1 Q9UDY8 1/20 0.39
PDE4B Q07343 3/20 0.38
PTGDR2 Q9Y5Y4 1/20 0.35
GRM5 P41594 2/20 0.34
PDE4A P27815 1/20 0.34
PDE4C Q08493 1/20 0.34
PRKAA2 P54646 4/20 0.34
DRD2 P14416 7/20 0.34
DRD3 P35462 7/20 0.34
HTR2A P28223 3/20 0.34
PRKAB2 O43741 1/20 0.33
PRKAG1 P54619 1/20 0.33
PRKAA1 Q13131 1/20 0.33
PRKAG3 Q9UGI9 1/20 0.33
PRKAG2 Q9UGJ0 1/20 0.33
PRKAB1 Q9Y478 1/20 0.33
ALDH1A1 P00352 1/20 0.33
LMNA P02545 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
RIPK1 Q13546 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31069313 1.00 MALT1 (0.39) MALT1PDE4BPTGDR2GRM5PDE4A
SCHEMBL23645439 1.00 MALT1 (0.39) MALT1PDE4BPTGDR2GRM5PDE4A
SCHEMBL23645363 0.83 MALT1 (0.42) MALT1PDE4BPDE4APDE4CPRKAA2
SCHEMBL23645358 0.83 MALT1 (0.42) MALT1PDE4BPDE4APDE4CPRKAA2
SCHEMBL21810902 0.82 MALT1 (0.41) MALT1PDE4BPDE4APDE4CPRKAA2
SCHEMBL23645359 0.80 MALT1 (0.41) MALT1PDE4BGRM5PDE4APDE4C
SCHEMBL23645355 0.80 MALT1 (0.41) MALT1PDE4BGRM5PDE4APDE4C
SCHEMBL23645335 0.79 PDE4B (0.41) MALT1PDE4BPDE4APDE4CPRKAA2
SCHEMBL23645331 0.79 PDE4B (0.41) MALT1PDE4BPDE4APDE4CPRKAA2
SCHEMBL23645317 0.79 MALT1 (0.40) MALT1PDE4BPDE4APDE4CPRKAA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12421225-B2 Heteroaromatic amide derivative and medicament containing the same KAKEN PHARMACEUTICAL CO., LTD. (JP) 2025-09-23 US disclosed
EP-3851436-B1 NOVEL HETEROAROMATIC AMIDE DERIVATIVE AND MEDICINE CONTAINING SAME KAKEN PHARMA CO LTD (JP) 2024-06-12 EP disclosed
US-20230086366-A1 Novel heteroaromatic amide derivative and medicament containing the same KAKEN PHARMACEUTICAL CO., LTD. (JP) 2023-03-23 US disclosed
EP-3851436-A1 NOVEL HETEROAROMATIC AMIDE DERIVATIVE AND MEDICINE CONTAINING SAME Kaken Pharmaceutical Co., Ltd. (JP) 2021-07-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230086366-A1 Novel heteroaromatic amide derivative and medicament containing the same SCN7A, HCN4, SCN4A MALT1 2051/4885PDE4B 1065/4885PTGDR2 3116/4885
US-12421225-B2 Heteroaromatic amide derivative and medicament containing the same SCN7A, HCN4, SCN4A MALT1 2096/4885PDE4B 967/4885PTGDR2 2536/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.